Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

LCAM for Hereditary Cancer Screening in Patients with Cancer, IMAGINE Study

Trial Status: active

This clinical trial tests how well a linguistically and culturally appropriate mainstreaming (LCAM) model for hereditary cancer multigene panel testing (MGPT) works among cancer patients who speak different languages and have diverse cultural and educational backgrounds. Genetic testing is a type of test that detects changes to the genes—the deoxyribonucleic acid (DNA) instructions that are passed on from the mother and father. The results of a genetic test can confirm whether the participant has a genetic disorder, which is a disease caused in whole or in part by changes to the genes. Genetic testing can also help determine a person’s chance of getting or passing on a genetic disorder. LCAM utilizes educational and clinical communication materials in order to offer patients streamlined access to multigene panel germline genetic testing through standardized education and test ordering by their oncologist/surgeon followed by post-test genetic counseling. LCAM may help patients from diverse cultural and educational backgrounds have better access to genetic testing and feel satisfied with their experience.